PD

Prakash Dnyaneshwar Kharabi

Active Director Director DIN 07112014
DIN 07112014 First appointment Jun 2015 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Prakash Dnyaneshwar Kharabi

Data last updated:

Prakash Dnyaneshwar Kharabi is a Director at Dative Pharma Private Limited (since 2015). The company operates in Healthcare.

DIN 07112014
Primary Designation Director
Industry Healthcare
First Appointment 29 Jun 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dative Pharma Private Limited U24232PN2015PTC155589
Director29 Jun 20152015Active

Board colleagues of Prakash Dnyaneshwar Kharabi

Directorship timeline

Open interactive timeline →
Dative Pharma Private Limited
Premium access

Shareholding and investment profile for Prakash Dnyaneshwar Kharabi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prakash Dnyaneshwar Kharabi

Prakash Dnyaneshwar Kharabi currently holds 1 directorship: Dative Pharma Private Limited (Director, since 29 Jun 2015).

Prakash Dnyaneshwar Kharabi was first appointed on 29 Jun 2015 as Director at Dative Pharma Private Limited.

The current boards of Prakash Dnyaneshwar Kharabi's companies include Padmakar Limbrao Gore (Dative Pharma Private Limited), Rajkumar Parappa Arali (Dative Pharma Private Limited), Vishwas Maruti Kadam (Dative Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available